High iron needs and low-iron diets combine to make early childhood one of the highest risk periods for iron deficiency. Recommendations for iron supplementation for this age group have been based on positive effects on anemia and child development. In contrast, the evidence regarding growth and morbidity outcomes has been equivocal, with some evidence of risk. The new evidence from Nepal and Zanzibar is reviewed, and possible interpretations are discussed. The Zanzibar trial found significant adverse effects in the overall population with poor malaria services and substantial benefit to iron-deficient children (the majority) in an area where access to treatments was provided. Cost-effectiveness analysis suggests that targeting supplements to iron-deficient children in Zanzibar may not increase costs (relative to universal supplementation) and would increase benefit. Operations research is needed to test this. We conclude with three options for maximizing the benefits and minimizing the risks of iron supplements.
StoltzfusRJMullanyLBlackRE. Iron deficiency anaemia. Comparative Quantification of Health Risks: Global and Regional Burden of Disease Attributable to Selected Major Risk Factors. Volume 1. Geneva: World Health Organization2005:163–209.
2.
RuelMTMenonPLoechlCPeltoG. Donated fortified cereal blends improve the nutrient density of traditional complementary foods in Haiti, but iron and zinc gaps remain for infants. Food Nutr Bull2004;25:361–76.
3.
StoltzfusRJDreyfussML. Guidelines for the use of iron supplements to prevent and treat iron deficiency anemia. Washington DC: ILSI Press, 1998.
4.
UNICEF, UNU, WHO. Iron deficiency anaemia. Assessment, prevention and control. WHO/NHD/01.3. Geneva: World Health Organization, 2001.
5.
WHO, UNICEF. Guidelines for the control of iron deficiency. WHO-EM/NUT/177,E/G/11.96. Alexandria: Bafra Graphics, 1996.
6.
INACG Consensus Statement. Safety of iron supplementation programs in malaria-endemic regions. Washington: ILSI, 1999.
7.
IannottiLLTielschJMBlackMMBlackRE. Iron supplementation in early childhood: Health benefits and risks. Am J Clin Nutr2006;84:1261–76.
8.
Grantham-McGregorSAniC. A review of studies on the effect of iron deficiency on cognitive development in children. J Nutr2001;131:649S–66S.
9.
LozoffB. Iron Deficiency and Child Development. Food and Nutr Bull2007;28:560–71.
10.
RamakrishnanUAburtoNMcCabeGMartorellR. Multimicronutrient interventions but not vitamin a or iron interventions alone improve child growth: Results of 3 meta-analyses. J Nutr2004;134:2592–602.
11.
SachdevHGeraTNestelP. Effect of iron supplementation on physical growth in children: Systematic review of randomised controlled trials. Public Health Nutr2006;9:904–20.
12.
UNICEF/UNU/WHO/MI. Preventing iron deficiency in women and children. Technical consensus on key issues. Boston: International Nutrition Foundation, 1999.
13.
WeinbergED. Iron witholding: A Defense against infection and neoplasia. Physiol Rev1984;64:65–102.
14.
DeMaeyerEMDallmanPGurneyJMHallbergLSoodSKSrikantiaSG. Preventing and controlling iron deficiency anaemia through primary health care: a guide for health administrators and programme managers. World Health Organization: Geneva, 1989.
15.
INACG. Guidelines for the eradication of iron deficiency anemia. New York: The Nutrition Foundation, 1977.
16.
OppenheimerSJ. Iron and its relation to immunity and infectious disease. J Nutr2001;131:616S–35S.
17.
GeraTSachdevHP. Effect of iron supplementation on incidence of infectious illness in children: Systematic review. Brit Med J2002;325:1142.
18.
van den HomberghJDalderopESmitY. Does iron therapy benefit children with severe malaria-associated anaemia? A clinical trial with 12 weeks supplementation of oral iron in young children from the Turiani Division, Tanzania. J Trop Pediatr.1996;42:220–7.
19.
DesaiMRMeiJVKariukiSK. Randomized, controlled trial of daily iron supplementation and intermittent sulfadoxine-pyrimethamine for the treatment of mild childhood anemia in western Kenya. J Infect. Dis.2003;187:658–66.
20.
VerhoefHWestCENzyukoSM. Intermittent administration of iron and sulfadoxine-pyrimethamine to control anaemia in Kenyan children: A Randomised controlled trial. Lancet2002;360:908–14.
21.
MenendezCKahigwaEHirtR. Randomised placebo-controlled trial of iron supplementation and malaria chemoprophylaxis for prevention of severe anaemia and malaria in Tanzanian infants. Lancet1997;350:844–50.
22.
AdamZ. Iron supplementation and malaria: a randomized, placebo-controlled field trial in rural Ethiopia (Ph.D. Thesis). London: London School of Tropical Medicine and Hygiene, 1997.
23.
SnowRWCraigMDeichmannUMarshK. Estimating mortality, morbidity and disability due to malaria among Africa's non-pregnant population. Bull WHO1999;77:624–40.
24.
TielschJMKhatrySKStoltzfusRJ. Effect of routine prophylactic supplementation with iron and folic acid on preschool child mortality in southern Nepal: Community-based, cluster-randomised, placebo-controlled trial. Lancet2006;367:144–52.
25.
SazawalSBlackRERamsanM. Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: Community-based, randomised, placebo-controlled trial. Lancet2006;367:133–43.
26.
EnglishMSnowRW. Iron and folic acid supplementation and malaria risk. Lancet2006;367:90–1.
27.
KarigerPKStoltzfusRJOlneyD. Iron deficiency and physical growth predict attainment of walking but not crawling in poorly nourished Zanzibari infants. J Nutr.2005;135:814–9.
28.
StoltzfusRJChwayaHMAlbonicoMSchulzeKSavioliLTielschJ. Serum ferritin, erythrocyte protoporphyrin and hemoglobin are valid indicators of iron status of school children in a malaria-holoendemic population. J Nutr1997;127:293–8.
29.
StoltzfusRJChwayaHMMontresorAAlbonicoMSavioliLTielschJ. Malaria, hookworms and recent fever are related to anemia and iron status indicators in 0- to 5-y old Zanzibari children and these relationships change with age. J Nutr2000;130:1724–33.
30.
EdejerTTAikinsMBlackRWolfsonLHutubessyREvansDB. Cost effectiveness analysis of strategies for child health in developing countries. Brit Med J2005;331:1177.
31.
Tanzania Sensa 2002. 2002Population and Housing Census. Government of Tanzania. www.tanzania.go.tz/census/. Accessed 27 August 2007
RussellLBSiegelJEDanielsNGoldMRLuceBRMandelblattJS. Cost-effectiveness analysis as a guide to resource allocation in health: Roles and limitations. In: GoldMRSiegelJERussellLBWeinsteinMC, eds. Cost-effectiveness in health and medicine. Oxford: Oxford University Press1996:3–24.
34.
LoevinsohnBPSutterRWCostalesMO. Using cost-effectiveness analysis to evaluate targeting strategies: The case of vitamin A supplementation. Health Policy Plan.1997;12:29–37.
35.
StantonNVGunterEWParsonsPJFieldPH. Empirically determined lead-poisoning screening cutoff for the Protofluor-Z hematofluorometer. Clin Chem1989;35:2104–7.
36.
Dept. of Health and Human Services. Agency for toxic substances and disease registry. What tests can assist with the diagnosis of lead toxicity?www.atsdr.cdc.gov/csem/lead/pbtests_diagnosis2.html. Accessed 27 August 2007.
37.
KellyAEHaddixACScanlonKSHelmickCGMulinareJ. Cost-effectiveness of strategies to prevent neural tube defects. In: GoldMRSiegelJERussellLBWeinsteinMC, eds. Cost-effectiveness in health and medicine. New York: Oxford University Press1996:313–48.
38.
SchellenbergDCisseBMenendezC. The IPTi Consortium: Research for policy and action. Trends Parasitol2006.
39.
MenendezCSchellenbergDQuintoL. The effects of short-term iron supplementation on iron status in infants in malaria-endemic areas. Am J Trop Med Hyg2004;71:434–40.
